HILLEVAX Trademark

Trademark Overview

On Monday, March 22, 2021, a trademark application was filed for HILLEVAX with the United States Patent and Trademark Office. The USPTO has given the HILLEVAX trademark a serial number of 90593423. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by Hillevax, Inc.. The HILLEVAX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
hillevax

General Information

Serial Number90593423
Word MarkHILLEVAX
Filing DateMonday, March 22, 2021
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7037764
Registration DateTuesday, April 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 24, 2021
Primary Code042
First Use Anywhere DateMonday, January 31, 2022
First Use In Commerce DateMonday, January 31, 2022

Trademark Owner History

Party NameHillevax, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameHillevax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameHillevax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101

Trademark Events

Event DateEvent Description
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, March 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 19, 2023USE AMENDMENT FILED
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 19, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, July 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 22, 2022SOU EXTENSION 1 GRANTED
Friday, July 22, 2022SOU EXTENSION 1 FILED
Friday, July 22, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 26, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 26, 2021ASSIGNED TO EXAMINER
Thursday, June 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 25, 2021NEW APPLICATION ENTERED

Related Keywords

hillevax development research pharmaceutical